Finland· FI-REL-REL28033

Trospium Verman

A trospium product containing trospium chloride, registered in Finland by Oy Verman Ab. The same ATC class is registered in 9 of our 19 countries.

ATC G04BD09

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTrospium VermanATCG04BD09REGISTER NO.FI-REL-REL28033PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Trospium is registered in 9 of 19 countries.

Countries holding a registration under ATC G04BD09 (trospium), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Trospium · ATC G04BD09

9 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trospium costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trospium · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.71
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Trospium chloride
Manufacturer
Oy Verman Ab
Country
Finland (FI)
ATC code
G04BD09
ATC class
Trospium
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    044976
    60
    EUR 24.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

254 interactions on record for trospium.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trospium · interactions on record

254 records

  • 6 severe
  • 202 moderate
  • 13 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trospium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trospium products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Inkontan, Spasmolyt
  • Bulgaria · Инконтан, Спазмо-Лит
  • Czechia · Spasmed, Uraplex
  • Germany · Spasmex, Spasmex Tc
  • Denmark · Spasmo-Lyt, Spasmo-Lyt Depot
  • Estonia · Spasmed
  • Spain · Uraplex
  • France · Ceris, Chlorure De Trospium Viatris
  • United Kingdom (Northern Ireland) · Regurin, Regurin Xl
  • Croatia · Spasmex
  • Hungary · Descalon
  • Ireland · Regurin
  • Italy · Urivesc
  • Luxembourg · Spasmex, Spasmo-Urgenin Tc
  • Portugal · Cloreto De Tróspio Farmoz, Cloreto De Tróspio Generis
  • Romania · Inkontan
  • Slovenia · Spasmex
  • Slovakia · Spasmed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/240eb38d-f8cf-4149-bde7-a0d6f2c3fcd1
GET /v1/drugs/240eb38d-f8cf-4149-bde7-a0d6f2c3fcd1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "20 mg",
  "atc_label": "trospium",
  "ma_number": "23245",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL28033",
  "authorised_at": "2010-01-11"
}

See everything about trospium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.